Showing posts with label Pharmacy. Show all posts
Showing posts with label Pharmacy. Show all posts

Tuesday, April 14, 2015

FAMU Biomedical Science Bridges Program producing award-winning results

As the spring semester nears to a close at FAMU, the Bridges to the Baccalaureate in the Biomedical Sciences Program is preparing to open its doors to 20 students from Tallahassee Community College (TCC) who are poised to become the next generation of leaders in biomedical sciences.

In its second year, the Bridges program is housed in the FAMU College of Pharmacy and Pharmaceutical Sciences (COPPS). It is a 10-week summer research experience partnership between FAMU and TCC that provides students with the academic skills, research training, and support network necessary for successful careers in fields related to science, technology, engineering, and mathematics (STEM), namely the biomedical sciences.

Friday, February 13, 2015

FAMU’s Center for Health Equity pursues CDC recognition for Diabetes Intervention Program

The FAMU Center for Health Equity (CHE) is pursuing “recognition status” by the Centers for Disease Control and Prevention (CDC) as a provider of the CDC’s lifestyle intervention program, which focuses on diabetes prevention.

Three researchers in the FAMU CHE – Otis Kirksey, Cynthia Seaborn, and Fajr Hassan – recently completed the required training to become certified to deliver the National Diabetes Prevention Program curriculum. The two-day training was provided by Emory University Rollins School of Public Health.

“The Center for Health Equity’s focus has been on diabetes management and education,” said Kirksey, professor and eminent scholar chair in pharmacy practice. “The recent training we received at Emory University’s School of Public Health will enable us to expand our scope to include a much needed diabetes prevention component for underserved populations in the state.”

Monday, January 26, 2015

Pharmacy Phase II scheduled for completion in Spring 2016

The construction of the Phase II building of the FAMU College of Pharmacy and Pharmaceutical Sciences is scheduled to finally reach the finish line in Spring 2016.

Last summer, Gov. Rick Scott signed a 2014-2015 Florida budget that included $10M for the construction project. Pharmacy Phase II will include much-needed laboratory and classroom space. FAMU Pharmacy needs this expansion in order to remain in compliance with the standards of the Accreditation Council of Pharmacy Education.

Wednesday, December 03, 2014

FAMU, UF partner to create Florida Minority Cancer Research and Training Center

FAMU Professor Renee Reams, principal investigator
By Lindy Brounley
UF Health Cancer Center

For many underrepresented minorities, pursuing careers in cancer research can be daunting. Nontraditional academic backgrounds and lack of exposure to research experiences often are impediments to underrepresented minorities’ preparedness for successful cancer research careers.

These minority students and investigators will now have support from the Florida Minority Cancer Research and Training Center, the state’s first and only National Cancer Institute minority institution/cancer center partnership focused on cancer research and training for African-Americans.

Funded by a $1.3-million award from the NCI — augmented with $320,000 in funding from the University of Florida Health Cancer Center — the center is administered by scientists from UF and Florida A&M University to provide research mentoring and training opportunities that burnish minority students’ and junior faculty members’ research skills, better preparing them for biomedical careers that could impact cancer health disparities in Florida’s minority communities.

Tuesday, September 30, 2014

Mangum: FAMU’s Crestview campus fulfilling mission to help Northwest Florida’s families

FAMU Crestview pharmacy students during a community service project
In a recent op-ed published by the Pensacola News Journal, FAMU President Elmira Mangum touted how the university’s Crestview campus is making a difference in Northwest Florida.

The opinion piece appeared shortly after the Crestview Bulletin highlighted a community service project led by students at the FAMU pharmacy school’s Crestview center.

From the FAMU president’s op-ed:

On Friday, Florida Agricultural and Mechanical University (FAMU) will celebrate its 127th anniversary. This marks an important time in the university’s history. We are celebrating more than a century of providing affordable access to education for Floridians, holding true to our founding mission as an 1890 land-grant institution dedicated to the advancement of knowledge, resolution of complex issues, and the empowerment of citizens and communities.

Just over two years ago, FAMU expanded its mission into the Pensacola area after opening the FAMU College of Pharmacy and Pharmaceutical Sciences Crestview Instructional Center. Currently, the center provides an opportunity for more than 70 future pharmacists, many of whom are from Escambia County and low-wealth families. Students receive training from FAMU’s nationally renowned faculty, as well as an opportunity to translate the knowledge they gain into careers that focus on community service.

Monday, July 21, 2014

National Cancer Institute funds $182,126 research project at FAMU pharmacy school

Mandip Singh Sachdeva, a professor in the FAMU College of Pharmacy and Pharmaceutical Sciences, has received a $182,126 research grant from the National Cancer Institute. The funds were awarded to support a project entitled: “Role of Telmisartan on Intra-Tumoral Distribution of Targeted Nanoparticles.”

The project’s abstract states that: “Our laboratory has been working with the use of inhalation and oral delivery of anticancer agents for treatment of lung cancer. Active targeting of chemotherapeutic drugs containing nanoparticles may effectively treat adenocarcinomas by achieving higher concentration at target sites.”

A nanoparticle is a microscopic object that is between 0.1nm and 100nm. Sachdeva is exploring how an experimental treatment that combines the use of certain nanoparticles with a drug named Telmisartan might improve the body's ability to fight cancer.  

The project began on April 1, 2014 and will continue through March 31, 2016.

Sacheva has brought more than $25 million in research grants to FAMU since he began teaching at the university in 1993.

Sunday, June 29, 2014

Santaluces High School valedictorian choses FAMU pharmacy school

Jazz-Lynn Butler performs a step routine.
In Fall 2014, the valedictorian of Santaluces High School in Lantana, Fla. will join the new freshman class at FAMU. She has accepted an offer of admission into the College of Pharmacy and Pharmaceutical Sciences.

From the Palm Beach Post:

Jazz-Lynn Butler doesn’t just have an unusual name - The 18-year-old Boynton Beach resident will tell you herself, she’s different.

“I was born with an umbilical cord wrapped around my left foot,” said Butler. “I was just born different, I’m very unusual.”

So it wasn’t a shocker when she stood out once again, academically, as Santaluces High School’s 2014 valedictorian. Her GPA was 3.88 but she confesses her HPA of 4.65 put her above the competition by merely a point.

Tuesday, June 10, 2014

Mangum working to expand FAMU’s role in STEM research

One day after Gov. Rick Scott signed a budget the pumped millions of additional dollars into FAMU’s STEM programs, President Elmira Mangum spoke about her vision to expand the university’s research activities in those critical areas.

Mangum told the Economic Club of Florida on June 3 that she wants to bring in more funds to support professors who are conducting cutting-edge research in the STEM (science, technology, engineering, and mathematics) fields.

“Our faculty members are engaged in research and my goal is to fund them in a way that they can continue to spend more time on research activity as well as attract new graduate students and increase our research efforts,” Mangum said. “Those are resources that also benefit our undergraduate program and attract students to our campus. My vision is to increase, significantly, that research funding by 2019. I am convinced that we have the talent and resources currently available to meet that objective.”

Mangum specifically called attention to the more than 30 patents secured by FAMU professors and said she wants to work with those faculty members to “monetize” that research.

Tuesday, June 03, 2014

Scott signs biggest FAMU budget of his term, spares all the university’s line items

Senate Pres. Don Gaetz (left), Gov. Rick Scott (center), and House Speaker Will Weatherford (right)
On Monday, FAMU received its best budgetary news since Gov. Rick Scott took office. The governor signed the biggest FAMU budget of his term and spared all of the university’s line items.

FAMU received $84,817,515 in General Revenue and $14,834,223 from the Education Enhancement Trust Fund, the largest respective amounts in four years.

The budget also includes a critical $10,000,000 that will help FAMU complete the Phase II building for the College of Pharmacy and Pharmaceutical Sciences.

Thursday, May 01, 2014

FAMU pharmacy professor secures $14M grant from the National Institutes of Health

FAMU College of Pharmacy and Pharmaceutical Sciences Associate Dean for Research Karam F.A. Soliman has secured a five-year grant totaling more than $14 million to support the Florida A&M University Research Centers in Minority Institutions (RCMI).

The grant was awarded by the U.S. Department of Health & Human Service’s National Institutes of Health. The FAMU RCMI was originally established in 1985, and serves as a hub for drug research and discovery with a mission of inventing and improving methods to close the gap in health disparities among minorities, and more specifically the African-American community.

Wednesday, April 30, 2014

Budget conference report includes $10M for Pharmacy Phase II

On Monday, Florida House and Senate budget negotiators agreed on a $75B budget for 2014-2015. The conference report includes $10M to help FAMU complete Phase II of FAMU’s College of Pharmacy and Pharmaceutical Sciences building.

Pharmacy Phase II will include much-needed laboratory and classroom space. FAMU Pharmacy needs this expansion in order to remain in compliance with the standards of the Accreditation Council of Pharmacy Education.

Thursday, March 27, 2014

FAMU public health students secure perfect passage rate on national CHES exam

Cynthia Harris, director, FAMU Institute of Public Health
Since 2009, 19 students have become eligible to take the Certified Education Health Specialist
(CHES) credentialing exam at the FAMU Institute of Public Health. Each of those students successfully passed the exam, allowing FAMU to hold the distinction of having a 100 percent pass rate on one of the nation’s most respected health education competency exams.

The Institute of Public Health recently learned that it once again achieved this feat, securing a 100 percent pass rate on the 2013 exam and surpassing the national average score of 71.56 percent.

To succeed in passing the CHES exam, students must display extensive knowledge in the seven areas of responsibility expected of health education specialists: assessment needs, planning of programs, program implementation, evaluation of programs, program administration, acting as a resource and communications and advocacy.

Monday, October 14, 2013

FAMU College of Pharmacy to celebrate launch of Center for Health

The FAMU College of Pharmacy and Pharmaceutical Sciences will host a reception today to celebrate the launch of the Center for Health Equity.

“The Center for Health Equity has been developed to further the College of Pharmacy and Pharmaceutical Sciences’ mission by improving the health care of medically underserved populations through research, education, community intervention and service,” said Michael Thompson, PharmD, dean of the FAMU College of Pharmacy and Pharmaceutical Sciences.

This cutting-edge center represents a new inter-professional approach to identifying and solving problems related to health disparities on a local, statewide, national and global scale and involves pharmacy faculty working cooperatively with nursing, psychology, social work, medicine and public health faculty at FAMU.

Wednesday, August 21, 2013

FAMU receives $13.7M grant from Research Center in Minority Institutions

FAMU Pharmacy Professor Karam Soliman, principal investigator and a multi-million dollar grant-raiser
FAMU has been awarded $13.7 million in grants for five-years of support through the Research Center in Minority Institutions (RCMI) Program from the National Institutes of Health’s (NIH) National Institute on Minority Health and Health Disparities (NIMHD).

“The RCMI program at FAMU is designed to strengthen and expand biomedical research and research infrastructure in a major way,” said Ken Redda, professor of medicinal chemistry and interim vice president for research. “Kudos is to Dr. Karam Soliman, Dr. Carl Goodman and their terrific team in generating this significant research funding from the National Institute on Minority Health and Health Disparities. It is a bright day at FAMU.”

The RCMI grant award for the period of 2013-2018 will support drug discovery and research aimed at better understanding the makeup and risks associated with various degenerative diseases and their treatment.  The grant also will support projects in drug discovery, molecular genetics and   biotechnology research. In the area of drug discovery, the grant will aid in developing new drugs that can be used for the treatment of neurodegenerative diseases such as Parkinson’s; stroke; cancer (breast, prostate and lung); and emerging infectious diseases to uncover targets for therapy and translational research.

Tuesday, July 09, 2013

FAMU Institute of Public Health’s accreditation extended through 2020

The Council on Education for Public Health (CEPH) extended the accreditation of the FAMU Institute of Public Health through July 1, 2020. Far from a small feat, this date will mark 20 years of consecutive accreditation for the flagship program. In addition, CEPH rendered the FAMU Public Health Program as compliant on all accreditation criteria.

“I am elated to learn that our public health program has, once again, attained the maximum accreditation tenure possible from the national accrediting body,” said Cynthia Harris, FAMU Institute of Public Health director (pictured). “This achievement is the result of an outstanding team of faculty, staff, students, administrators, alumni, advisory board and a wonderful cadre of supportive community stakeholders.”

Annually, the public health program, which is housed in the College of Pharmacy and Pharmaceutical Sciences, develops and produces culturally competent public health practitioners and leaders through graduate training, research and service. The Institute of Public Health was created by the Florida Legislature in 1995. Subsequently, FAMU was given authority to initially offer the Master of Public Health (MPH) degree. Since that time, the program has grown and now offers the Doctor of Public Health (DrPH). The FAMU Public Health Program was the first accredited public health program in North Florida and the first public health program, including schools of public health, to offer the Doctor of Public Health in the state of Florida.

Friday, June 21, 2013

FAMU student wins statewide health science competition

FAMU doctoral student Terrick Andey recently won first place in the Health Sciences category during the inaugural Statewide Graduate Research Symposium. Hosted by the University of South Florida, the symposium brought together 75 graduate students from various disciplines across eight universities. Andey’s poster was titled, “Liposomal Annexin A2 Small Hairpin RNA-mediated Inhibition of Angiogenesis in Lung Cancer Stem Cells.”

“I was definitely thrilled to have had those long and lonely hours of research work recognized on such a platform,” said Andey, a Ghana native. “I perceive the award to be a validation of the progressive research environment that FAMU has has been fostering.”

Tuesday, April 16, 2013

Florida House budget includes $4M for Pharmacy Phase II

The 2013-2014 Florida House of Representatives budget appropriates $4M for Phase II of FAMU’s College of Pharmacy and Pharmaceutical Sciences building. Pharmacy Phase II is FAMU’s top construction priority.

Pharmacy Phase II will include much-needed laboratory and classroom space. FAMU Pharmacy needs this expansion in order to remain in compliance with the standards of the Accreditation Council of Pharmacy Education.

There is a total of $68M for Public Education Capital Outlay (PECO) projects in the Florida’s House’s budget. PECO dollars come from utility taxes. The state has had very little PECO money in recent years due to housing market crash and citizens shaving their energy costs by purchasing more energy efficient appliances.

Thursday, March 21, 2013

FAMU Pharmacy Phase II and Crestview campus remain top legislative priorities

Florida economists predict that the state could receive an extra $3.5 billion in tax revenue during the fiscal year ending in 2014. FAMU only needs $11,480,000 of that, barely 0.3 percent, in order to fund two budget priorities that are critical to a key research program.

The FAMU College of Pharmacy and Pharmaceutical Sciences (COPPS) remains one of the university’s top, multi-million dollar research centers. It is leading clinical and laboratory investigations to find solutions to health problems such as cancer, HIV, and “superbug” bacteria.

The university still needs $11.4M to finish up the Pharmacy Phase II building. Without that money, COPPS might be in jeopardy of failing to meet the laboratory and classroom space requirements of the Accreditation Council for Pharmacy Education.

Wednesday, March 20, 2013

FAMU pharmacy professor receives patent to kill “superbug”

Seth Y. Ablordeppey, a professor of medicinal chemistry in the College of Pharmacy and Pharmaceutical Sciences (COPPS), has received a patent to kill a “superbug” that has made headlines.

The Methicillin-Resistant Staphylococcus aureus (MRSA) is a staph infection that is commonly called a “superbug” because it is resistant to common antibiotics. Ablordeppey is developing drug compounds to combat it using plants he found in Ghana, West Africa.  His tests have revealed antibacterial activity in the plants that heals wounds.  He is looking at their extracts to see if one will kill MRSA.

If the process is successful, it could lead an inexpensive superbug treatment.

“We wanted some simple compounds that we can synthesize in a very short period of time and we are looking towards getting compounds which are not that expensive so that people can afford them,” Ablordeppey said.